Clinical trial registry record

Study of JMKX003948 Ophthalmic Suspension in Healthy Participants

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Not Yet Recruiting.
Evidence
Registered phase 1 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 18, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06832657
Last registry update
February 18, 2025
Status
Not Yet Recruiting
Phase
Phase 1
Sponsor
Jemincare
Enrollment
40
Match confidence
60%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 1
Study design
RANDOMIZED · SEQUENTIAL · TREATMENT · QUADRUPLE
Evidence population
Human clinical study registration
Participants
40
Population
ALL · 18 Years to 45 Years
Duration
2025-02-01 to 2025-12-01
Intervention
JMKX003948 Ophthalmic Suspension; Placebo
Comparator
Placebo
Outcomes measured
Adverse events (AEs) — From Day1 to up to Day14; Number of Participants With abnormal Ophthalmic examination — From Day1 to up to Day14; Maximum concentration (Cmax) — From Day1 to up to Day14; Area under the concentration-time curve — From Day1 to up to Day14; Time to Cmax (Tmax) — From Day1 to up to Day14; Elimination half-life (t1/2) — From Day1 to up to Day14
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 1A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 60% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Vision ageing · 60%Source terminology contains: age-related macular degeneration. Source terminology supplies longevity context: age-related. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

vision aging
Open primary sourceExport JSON